HeartFlow, Inc. is a medical technology company advancing the diagnosis and management of coronary artery disease, the #1 cause of death worldwide, using cutting-edge technology. The flagship product—an AI-driven, non-invasive cardiac test supported by the ACC/AHA Chest Pain Guidelines called the HeartFlow FFRCT Analysis—provides a color-coded, 3D model of a patient’s coronary arteries indicating the impact blockages have on blood flow to the heart. HeartFlow is the first AI-driven non-invasive integrated heart care solution across the CCTA pathway that helps clinicians identify stenoses in the coronary arteries (RoadMap™Analysis), assess coronary blood flow (FFRCT Analysis), and characterize and quantify coronary atherosclerosis (Plaque Analysis). Our pipeline of products is growing and so is our team; join us in helping to revolutionize precision heartcare.
HeartFlow is a VC-backed, pre-IPO company that has received international recognition for exceptional strides in healthcare innovation, is supported by medical societies around the world, cleared for use in the US, UK, Europe, Japan and Canada, and has been used for more than 250,000 patients worldwide.
Why HeartFlow?
HeartFlow is on a mission to defeat Heart Disease. We are doing this by transforming the way we diagnose and treat heart disease by combining deep clinical insights with cutting-edge AI. HeartFlow's technology has been adopted globally, with over 250,000 patients benefiting from its AI-driven non-invasive heart disease diagnosis. The technology is supported by extensive clinical research, published in more than 500 peer-reviewed articles. HeartFlow is now available at more than 90% of top Heart hospitals in the US with growing presence in EU, UK and Japan. We are a pre-IPO company, poised for profitability with a robust roadmap and financial runway. Joining us now offers a unique opportunity to be part of our journey to the public markets, alongside a team that is passionate about innovation and excellence in the healthcare sector. #LI-Remote; #LI-IB1
Why this team?
The product and design team at Heartflow is tasked with creatively discovering and relentlessly delivering novel, AI-powered software solutions that help our cardiologist and radiologist customers serve heart patients with greater speed, accuracy, and efficiency. This team is responsible for Heartflow's entire FDA-approved product portfolio that includes FFRct, Roadmap analysis and Plaque Analysis. We also design and manage software tools used internally for case processing, customer service, and R&D.
What you’ll focus on:
What you will do day-to-day:
What you’ll sometimes:
What is this role important?
As a Senior UX Designer at HeartFlow, you will lead the charge in creating intuitive, scalable, and engaging user experiences for the web for both internal and external users.
What we're looking for:
Educational background:
A reasonable estimate of the base salary compensation range is $100,000 to $152,500 (for all locations outside San Francisco Bay Area) and $130,000 to $180,250 (for San Francisco Bay Area), cash bonus, and stock options.
HeartFlow, Inc. is an Equal Opportunity Employer. We are committed to a work environment that supports, inspires, and respects all individuals and do not discriminate against any employee or applicant because of race, color, religion, marital status, age, national origin, ancestry, physical or mental disability, medical condition, pregnancy, genetic information, gender, sexual orientation, gender identity or expression, veteran status, or any other status protected under federal, state, or local law. This policy applies to every aspect of employment at HeartFlow, including recruitment, hiring, training, relocation, promotion, and termination. Positions posted for HeartFlow are not intended for or open to third party recruiters / agencies. Submission of any unsolicited resumes for these positions will be considered to be free referrals. US Locations Only: All employees and contingent workers (contractor, consultant, interns or temporary personnel) are required to be vaccinated against SARS-CoV-2 as recommended by CDC, unless a reasonable accommodation is approved. All prospective hires will be expected to provide proof of vaccination on their first day of employment.